![Prostate-Specific Antigen Testing: Overview, Physiologic Characteristics of PSA, Other Prostate Cancer Markers Prostate-Specific Antigen Testing: Overview, Physiologic Characteristics of PSA, Other Prostate Cancer Markers](https://img.medscapestatic.com/pi/meds/ckb/07/23507tn.jpg)
Prostate-Specific Antigen Testing: Overview, Physiologic Characteristics of PSA, Other Prostate Cancer Markers
![Ontario Ministry of Health and Long-Term Care - Health Care Providers Section - Publications - Cancer - Ontario Prostate Specific Antigen (PSA) Clinical Guidelines Ontario Ministry of Health and Long-Term Care - Health Care Providers Section - Publications - Cancer - Ontario Prostate Specific Antigen (PSA) Clinical Guidelines](https://www.health.gov.on.ca/english/providers/pub/cancer/psa/psa_guide/psa.gif)
Ontario Ministry of Health and Long-Term Care - Health Care Providers Section - Publications - Cancer - Ontario Prostate Specific Antigen (PSA) Clinical Guidelines
![Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.350.issue-22/nejmoa031918/production/images/img_medium/nejmoa031918_t2.jpeg)
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM
![QuickStats: Percentage of Men Aged <U>></U>40 Years* with Prostate-Specific Antigen (PSA) Levels of <U>></U>2.5 and <U>></U>4.0 ng/mL, by Race/Ethnicity --- National Health and Nutrition Examination Survey, United States, 2001--2004 QuickStats: Percentage of Men Aged <U>></U>40 Years* with Prostate-Specific Antigen (PSA) Levels of <U>></U>2.5 and <U>></U>4.0 ng/mL, by Race/Ethnicity --- National Health and Nutrition Examination Survey, United States, 2001--2004](https://www.cdc.gov/mmwr/preview/mmwrhtml/figures/m548qsf.gif)
QuickStats: Percentage of Men Aged <U>></U>40 Years* with Prostate-Specific Antigen (PSA) Levels of <U>></U>2.5 and <U>></U>4.0 ng/mL, by Race/Ethnicity --- National Health and Nutrition Examination Survey, United States, 2001--2004
![SciELO - Brasil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection SciELO - Brasil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection](https://minio.scielo.br/documentstore/1677-6119/rZqzS6ngfHjyJxNWvHmW5qy/4966e23dbbb57e0e806f4c569f2439f76166ebb8.gif)
SciELO - Brasil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection
![PDF] Reducing the Harm of Prostate Cancer Screening: Repeated Prostate-Specific Antigen Testing. | Semantic Scholar PDF] Reducing the Harm of Prostate Cancer Screening: Repeated Prostate-Specific Antigen Testing. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7780648a43dbe5395f3681978464f1d74d1c45f0/3-Table1-1.png)
PDF] Reducing the Harm of Prostate Cancer Screening: Repeated Prostate-Specific Antigen Testing. | Semantic Scholar
![Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2016/jco.2015.65.34.issue-23/jco.2016.66.7527/20161107/images/medium/jco667527t3.gif)
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology
![SciELO - Brasil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection SciELO - Brasil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection](https://minio.scielo.br/documentstore/1677-6119/rZqzS6ngfHjyJxNWvHmW5qy/975ba54879c3ed642b8aa78b3f1b3b744693e06a.gif)
SciELO - Brasil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection
![Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate](https://indianjurol.com/articles/2014/30/1/images/IndianJUrol_2014_30_1_28_124202_t3.jpg)
Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate
![Prostate specific antigen (PSA) as a long-term marker of risk for prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK Prostate specific antigen (PSA) as a long-term marker of risk for prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2008/04/newest-lilja-table.png)
Prostate specific antigen (PSA) as a long-term marker of risk for prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK
![Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine](https://www.thelancet.com/cms/attachment/624cfadd-1edd-4a95-853e-6264e72dfd82/gr1_lrg.jpg)
Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine
![Prostate-Specific Antigen Within the Reference Range, Subclinical Coronary Atherosclerosis, and Cardiovascular Mortality | Circulation Research Prostate-Specific Antigen Within the Reference Range, Subclinical Coronary Atherosclerosis, and Cardiovascular Mortality | Circulation Research](https://www.ahajournals.org/cms/asset/cb19e14f-b3bb-4a13-abba-cc81bdf9ac9c/1492fig01.gif)